Keep a list to show your healthcare provider and pharmacist when you get a new medicine
While this sounds encouraging, we must recognize this was not a controlled trial there was no placebo group, and the patients (and doctors) knew they were receiving the peptide
Retatrutide is an investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously currently progressing through Phase 3 clinical trials

Research reveals that platinum-resistant HGSOC cells often exhibit suppression of Homologous Recombination (HR) repair pathways, while alternative repair mechanisms, such as Non-Homologous End Joining (NHEJ), are activated ( Single-cell RNA sequencing has revealed specific drug-resistant cell subpopulations in HGSOC that promote their growth and drug resistance through interactions with fibroblasts and endothelial cells in the tumor microenvironment ( 3.3 Apoptosis and autophagy In the apoptotic pathways of tumor cells and HGSOC cells, key proteins such as the Bcl-2 family, p53, and caspases play crucial roles ( p53, as a tumor suppressor, promotes apoptosis by inducing the expression of apoptosis-related genes, particularly in cases of DNA damage ( Autophagy plays a dual role in the drug resistance of tumor cells and HGSOC

JM self-reports that his lifestyle could be improved in terms of both diet and physical activity, and interventions aimed at achieving weight loss would be beneficial